Resectable Prancreas Carcinoma
1 clinical trials · Condition
◉ Watch Resectable Prancreas Carcinoma
| Record | Firm | Date |
|---|---|---|
| Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma (NCT02172976) | Krankenhaus Nordwest | 2014-11-01 |
Track Resectable Prancreas Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.